102. ルビンシュタイン・テイビ症候群 Disease details / Clinical trials / Drug dev / DR info
臨床試験数 : 3 / 薬物数 : 5 - (DrugBank : 1) / 標的遺伝子数 : 7 - 標的パスウェイ数 : 17
薬物ごとの開発者(Primary Sponsor)、臨床試験情報(抜粋)です。
Culture of lymphoblastoid line from blood sample
University Hospital, Bordeaux
2019 - NCT04122742 France;
Depakine
CHU de bordeaux
- Phase 2 EUCTR2011-003784-30-FR France;
Skin biopsy for the primary fibroblast culture and a 15 ml blood sample (3 unnamed samples of 5ml) in each of the 4 SRT patients included.
University Hospital, Bordeaux
2019 - NCT04122742 France;
Sodium valproate
University Hospital, Bordeaux
2012 Phase 2 NCT01619644 France;
University Hospital, Bordeaux
2019 - NCT04122742 France;
Depakine
CHU de bordeaux
- Phase 2 EUCTR2011-003784-30-FR France;
Skin biopsy for the primary fibroblast culture and a 15 ml blood sample (3 unnamed samples of 5ml) in each of the 4 SRT patients included.
University Hospital, Bordeaux
2019 - NCT04122742 France;
Sodium valproate
University Hospital, Bordeaux
2012 Phase 2 NCT01619644 France;